CDK1 and ovarian cancer: Finally, Chang et al. [181] reported that SFN treatment decreased cell survival and proliferation, increased cell accumulation in the G2/M phase, and downregulated cell division cycle protein 2 (CDC2), causing dissociation of the cyclin B1/CDC2 complex in PA-1 ovarian cancer cells.